Researchers to Present Data on Immunovaccine's Infectious Disease Pipeline at Three International Conferences
Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical-stage vaccine and immunotherapy company, today announced planned data presentations at upcoming scientific meetings in conjunction with …